Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 28, 2018	Sep. 29, 2017
Current assets:
Cash and cash equivalents	$ 918,063	$ 627,017
Restricted cash	7,187	7,351
Short-term investments	178,138	247,757
Accounts receivable, net of allowance for doubtful accounts of $5,352 and $2,967	137,151	73,750
Inventories	26,206	25,051
Prepaid expenses and other current assets	35,209	30,508
Total current assets	1,301,954	1,011,434
Long-term investments	187,782	314,364
Property, plant and equipment, net	514,182	485,275
Intangible assets, net	184,019	189,648
Goodwill	327,982	311,087
Deferred taxes	101,070	190,915
Other non-current assets	42,280	30,831
Total assets	2,659,269	2,533,554
Current liabilities:
Accounts payable	21,922	14,373
Accrued liabilities	223,594	207,034
Income taxes payable	2,680	1,216
Deferred revenue	23,931	23,150
Total current liabilities	272,127	245,773
Long-term deferred revenue	40,064	36,425
Other non-current liabilities	150,960	107,514
Total liabilities	463,151	389,712
Stockholders' equity:
Additional paid-in capital	66,127	61,331
Retained earnings	2,139,154	2,083,063
Accumulated other comprehensive income	(15,832)	(7,753)
Total stockholders’ equity – Dolby Laboratories, Inc.	2,189,551	2,136,742
Controlling interest	6,567	7,100
Total stockholders’ equity	2,196,118	2,143,842
Total liabilities and stockholders’ equity	2,659,269	2,533,554
Class A Common Stock [Member]
Stockholders' equity:
Common stock	61	58
Class B Common Stock [Member]
Stockholders' equity:
Common stock	$ 41	$ 43